Chen et al. reviewed a series of 126 LARC patients treated with NCRT and found that the post-NCRT stromal-infiltrating CD8+ T cell density corresponded with tumour regression grades, distant metastasis rates, and DFS [28]. The gene discussed is CD8A; the disease is neoplasm.